Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TXG

10x Genomics Inc

Mar 27 • 04:00PM ET

19.48

-0.95 -4.65 %

Healthcare • Health Information Services • USA • NASD

Peers: ILMN NTRA PACB FLGT CDNA MYGN GH EXAS QDEL TWST

| Held by: ARKK VTI ARKG VB IWM VBK VXF IBB IWN VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.35	Insider Own	11.61%	Shs Outstand	117.61M	Perf Week	5.93%
Market Cap	2.49B	Forward P/E	-	EPS next Y	-0.64	Insider Trans	-0.66%	Shs Float	112.92M	Perf Month	-11.97%
Enterprise Value	2.05B	PEG	-	EPS next Q	-0.27	Inst Own	95.80%	Short Float	14.00%	Perf Quarter	16.72%
Income	-43.54M	P/S	3.87	EPS this Y	-138.43%	Inst Trans	3.11%	Short Ratio	6.12	Perf Half Y	63.01%
Sales	642.82M	P/B	3.12	EPS next Y	23.90%	ROA	-4.44%	Short Interest	15.81M	Perf YTD	19.44%
Book/sh	6.24	P/C	4.75	EPS next 5Y	-13.62%	ROE	-5.78%	52W High	23.56 -17.32%	Perf Year	107.01%
Cash/sh	4.10	P/FCF	19.13	EPS past 3/5Y	37.90% 42.10%	ROIC	-5.01%	52W Low	6.78 187.32%	Perf 3Y	-60.85%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.57% 16.55%	Gross Margin	70.38%	Volatility	5.70% 6.87%	Perf 5Y	-88.27%
Dividend TTM	-	EV/Sales	3.19	EPS Y/Y TTM	77.07%	Oper. Margin	-16.51%	ATR (14)	1.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.09	Sales Y/Y TTM	5.25%	Profit Margin	-6.77%	RSI (14)	49.17	Recom	2.50
Dividend Gr. 3/5Y	- -	Current Ratio	4.46	EPS Q/Q	68.28%	SMA20	-2.31%	Beta	2.18	Target Price	20.07
Payout	-	Debt/Eq	0.11	Sales Q/Q	0.61%	SMA50	-2.91%	Rel Volume	0.79	Prev Close	20.43
Employees	1178	LT Debt/Eq	0.09	Earnings	Feb 12 AMC	SMA200	24.75%	Avg Volume	2.58M	Price	19.48
IPO	Sep 12, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	35.90% 3.99%	Trades		Volume	2,051,460	Change	-4.65%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-11-25	Downgrade	Citigroup	Buy → Neutral
Dec-02-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$20
Sep-11-25	Initiated	Piper Sandler	Neutral	$15
Feb-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$25 → $12
Sep-03-24	Initiated	Leerink Partners	Outperform	$35
Jul-22-24	Upgrade	Jefferies	Hold → Buy	$24
Jul-18-24	Downgrade	JP Morgan	Overweight → Neutral	$40 → $20
Jul-10-24	Downgrade	Deutsche Bank	Buy → Hold	$55 → $25
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-25-24	Downgrade	Guggenheim	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Hold	$24
May-01-24	Downgrade	TD Cowen	Buy → Hold	$57 → $32
Dec-14-23	Initiated	Guggenheim	Buy	$60
Dec-13-23	Initiated	Wolfe Research	Outperform	$55
Dec-12-23	Upgrade	BofA Securities	Underperform → Neutral	$36 → $54
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-10-23	Initiated	Barclays	Overweight	$65
Mar-31-23	Initiated	Stephens	Overweight	$65
Feb-02-23	Initiated	UBS	Neutral	$50
Dec-14-22	Initiated	Deutsche Bank	Buy	$50

Show Previous Ratings

Mar-25-26 07:00AM	Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs (PR Newswire) +5.55%
Mar-24-26 06:00PM	Torex Gold Reports Year-End 2025 Reserves & Resources (TMX Newsfile)
Mar-17-26 08:00AM	PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas (PR Newswire) +8.39%
Mar-09-26 08:52AM	Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026? (Zacks)
Mar-05-26 10:41PM	Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers (StockStory)
10:15AM	Loading…
Mar-03-26 10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-19-26 04:05PM	10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference (PR Newswire)
12:38AM	5 Must-Read Analyst Questions From 10x Genomics's Q4 Earnings Call (StockStory)
Feb-18-26 09:41AM	Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy? (Zacks) +5.10%
Feb-13-26 11:30AM	Why Is 10x Genomics (TXG) Stock Soaring Today (StockStory)
08:30AM	10x Genomics, Inc. Q4 2025 Earnings Call Summary (Moby)
12:32AM	TXG Q4 Deep Dive: Consumables Growth, Spatial Expansion, and AI-Driven Demand Shape Outlook (StockStory)
12:04AM	10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations Amid ... (GuruFocus.com)
Feb-12-26 09:07PM	10x Genomics Q4 Earnings Call Highlights (MarketBeat) -8.56%
06:30PM	Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics (Zacks) -8.56%
05:30PM	Loading…
05:30PM	10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates (Zacks) -8.56%
04:54PM	10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 (StockStory) -8.56%
04:30PM	10x Genomics: Q4 Earnings Snapshot (Associated Press Finance) -8.56%
04:05PM	10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 (PR Newswire) -8.56%
Feb-10-26 10:07PM	10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-05-26 10:00AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks) -7.14%
Feb-04-26 09:00AM	PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology (PR Newswire)
Jan-30-26 02:48PM	Gold, Silver Crash Sparks Mining Meltdown: 10 Stocks Crater On Fed Warsh Shock (Benzinga)
Jan-22-26 04:05PM	10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (PR Newswire)
03:47AM	Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell (Zacks)
Jan-21-26 04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga)
09:53AM	3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes (Zacks)
Jan-20-26 12:05AM	Cathie Wood's Ark Unleashes Cryptic ARKmoji Teasers To Showcase Its 'Big Ideas' For 2026: Can You Take A Guess At The Hidden Meaning? (Benzinga) +7.46%
Jan-19-26 01:27PM	Cathie Wood Buys AI Chips, Sells Tesla (GuruFocus.com)
Jan-18-26 11:40PM	3 Hyped Up Stocks That Concern Us (StockStory)
04:05PM	Loading…
Jan-12-26 04:05PM	Why 10x Genomics (TXG) Shares Are Falling Today (StockStory)
09:11AM	10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease (PR Newswire)
09:10AM	10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling (PR Newswire)
09:00AM	Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology (PR Newswire)
Jan-11-26 12:00PM	10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results (PR Newswire)
Jan-07-26 07:05AM	CareDx and 10x Genomics to Launch ImmuneScape Program - A Multiomics Research Platform to Decode Transplant Rejection and Drug Response (Business Wire)
Jan-02-26 01:45PM	10x Genomics (TXG) Stock Is Up, What You Need To Know (StockStory)
Dec-29-25 04:05PM	10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-22-25 10:20PM	Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending (Insider Monkey)
11:56AM	10x Genomics (TXG) Stock Trades Up, Here Is Why (StockStory)
Dec-17-25 11:22AM	Tempus AI Turns Non-GAAP Profit on Surging Genomics and Data (Zacks)
Dec-16-25 09:07AM	Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up (Zacks)
Dec-15-25 11:30AM	Tempus AI Near $75 Target? Valuation, Upside and Risks (Zacks)
Dec-11-25 11:41AM	Why 10x Genomics (TXG) Stock Is Nosediving (StockStory)
Dec-07-25 10:32PM	Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders (StockStory)
Dec-02-25 09:34AM	Teradyne upgraded, Circle Internet initiated: Wall Street's top analyst calls (The Fly)
Nov-18-25 11:02PM	3 Reasons to Avoid TXG and 1 Stock to Buy Instead (StockStory)
09:00AM	New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium (PR Newswire)
Nov-15-25 11:42PM	10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch (Insider Monkey)
Nov-13-25 12:33AM	5 Insightful Analyst Questions From 10x Genomics's Q3 Earnings Call (StockStory)
Nov-11-25 04:05PM	10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 (PR Newswire)
12:51PM	10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat (Insider Monkey)
12:26PM	Why 10x Genomics (TXG) Stock Is Trading Up Today (StockStory)
07:29AM	Should You Buy, Hold or Sell TEM Stock Post Q3 Earnings Release? (Zacks)
Nov-07-25 04:06PM	Why 10x Genomics (TXG) Stock Is Trading Up Today (StockStory)
09:26AM	TXG Q3 Deep Dive: Spatial Biology and Consumables Drive Outperformance Amid Macro Uncertainty (StockStory)
06:36AM	Stock Market Today: U.S. Stock Futures Tumble After Overnight Reprieve, Extending Week-Long Tech Struggle (TheStreet)
Nov-06-25 07:00PM	Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:57PM	10x Genomics's (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% (StockStory)
04:52PM	10x Genomics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-05-25 05:41AM	Qiagen inks $225M single-cell buyout as CEO prepares to step down (MedTech Dive)
Nov-04-25 10:17PM	10x Genomics Earnings: What To Look For From TXG (StockStory)
Oct-30-25 10:00AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-29-25 01:39PM	Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? (Zacks)
09:00AM	10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research (PR Newswire)
Oct-21-25 05:19AM	10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? (Zacks)
Oct-20-25 12:30PM	10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences (PR Newswire)
11:35AM	Why Is 10x Genomics (TXG) Stock Rocketing Higher Today (StockStory)
11:23AM	Zacks.com featured highlights include Red Robin Gourmet Burgers, 10x Genomics, Norwegian Cruise Line, Electromed and Analog Devices (Zacks)
10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks)
09:03AM	Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy? (Zacks)
Oct-17-25 11:05AM	5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns (Zacks)
Oct-16-25 12:00PM	10x Genomics (TXG) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Oct-15-25 02:01PM	Why 10x Genomics (TXG) Stock Is Trading Up Today (StockStory)
Oct-10-25 03:51PM	10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know (StockStory)
Oct-09-25 04:05PM	10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 (PR Newswire)
Sep-16-25 12:33AM	3 Stocks Under $50 We Find Risky (StockStory)
Sep-12-25 02:25PM	10x Genomics (TXG) Stock Trades Down, Here Is Why (StockStory)
Sep-11-25 11:56AM	10x Genomics (TXG) Stock Is Up, What You Need To Know (StockStory)
Sep-09-25 08:44AM	TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell? (Zacks)
Aug-27-25 04:05PM	10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference (PR Newswire)
Aug-24-25 11:34PM	Q2 Earnings Highs And Lows: 10x Genomics (NASDAQ:TXG) Vs The Rest Of The Life Sciences Tools & Services Stocks (StockStory)
Aug-22-25 12:04AM	3 Reasons TXG is Risky and 1 Stock to Buy Instead (StockStory)
Aug-20-25 12:37AM	1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down (StockStory)
Aug-19-25 09:00AM	10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis (PR Newswire)
Aug-14-25 01:35AM	10x Genomics's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
12:45AM	1 Volatile Stock to Own for Decades and 2 That Underwhelm (StockStory)
Aug-12-25 10:03AM	Zacks.com featured highlights include Tsakos Energy Navigation Limited, 10x Genomics, Pan American Silver, Wolverine World Wide and Interface (Zacks)
Aug-11-25 09:37AM	TXG Q2 Deep Dive: Robust Product Demand and Cautious Outlook Amid Funding Uncertainty (StockStory)
07:41AM	5 Must-Buy Efficient Stocks to Buy Amid Volatile Market Conditions (Zacks)
Aug-08-25 12:21PM	Why 10x Genomics (TXG) Stock Is Falling Today (StockStory)
04:45AM	10x Genomics (NASDAQ:TXG) Reports Upbeat Q2, Stock Soars (StockStory)
Aug-07-25 06:30PM	10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:35PM	10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:33PM	10x Genomics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Second Quarter 2025 Financial Results (PR Newswire)
04:04PM	10x Genomics to Acquire Scale Biosciences (PR Newswire)
Aug-06-25 12:00PM	10x Genomics (TXG) Upgraded to Buy: Here's Why (Zacks)

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saxonov Serge	Chief Executive Officer	Mar 23 '26	Sale	19.13	10,000	191,297	1,177,273	Mar 25 05:15 PM
Saxonov Serge	Chief Executive Officer	Mar 24 '26	Sale	19.52	5,000	97,612	1,172,273	Mar 25 05:15 PM
Saxonov Serge	Chief Executive Officer	Mar 02 '26	Sale	22.73	16,152	367,097	1,203,667	Mar 04 04:14 PM
Serge Saxonov	Director, CEO	Mar 02 '26	Proposed Sale	22.13	41,152	910,694		Mar 02 04:21 PM
Teichmann Sarah A.	Director	Feb 25 '26	Sale	19.41	7,579	147,108	26,780	Feb 27 04:01 PM
Saxonov Serge	Chief Executive Officer	Feb 23 '26	Sale	18.58	9,632	178,928	1,061,924	Feb 25 04:52 PM
Taich Adam	Chief Financial Officer	Feb 23 '26	Sale	18.58	8,968	166,593	288,417	Feb 25 04:51 PM
Hindson Benjamin J.	See Remarks	Feb 23 '26	Sale	18.58	7,826	145,379	424,779	Feb 25 04:51 PM
SARAH A POLONIUS-TEICHMANN	Director	Feb 25 '26	Proposed Sale	19.41	7,579	147,108		Feb 25 04:44 PM
Hindson Benjamin J.	Officer	Feb 23 '26	Proposed Sale	19.19	8,301	159,269		Feb 23 05:30 PM
Saxonov Serge	Officer	Feb 23 '26	Proposed Sale	19.19	10,129	194,376		Feb 23 05:15 PM
Taich Adam	Officer	Feb 23 '26	Proposed Sale	19.19	9,188	176,318		Feb 23 05:00 PM
Saxonov Serge	Chief Executive Officer	Jan 05 '26	Option Exercise	1.20	50,000	60,000	1,071,556	Jan 07 04:52 PM
Taich Adam	Chief Financial Officer	Nov 24 '25	Sale	19.00	11,888	225,852	297,385	Nov 25 05:24 PM
Hindson Benjamin J.	See Remarks	Nov 24 '25	Sale	19.00	8,283	157,363	432,605	Nov 25 05:24 PM
Saxonov Serge	Chief Executive Officer	Nov 24 '25	Sale	19.00	13,261	251,936	1,021,556	Nov 25 05:23 PM
Hindson Benjamin J.	Officer	Nov 24 '25	Proposed Sale	18.34	7,392	135,569		Nov 24 05:32 PM
Saxonov Serge	Officer	Nov 24 '25	Proposed Sale	18.34	13,096	240,181		Nov 24 04:56 PM
Taich Adam	Officer	Nov 24 '25	Proposed Sale	18.34	11,312	207,462		Nov 24 04:28 PM
Saxonov Serge	Chief Executive Officer	Aug 22 '25	Sale	13.79	9,348	128,881	945,892	Aug 26 04:15 PM
Taich Adam	Chief Financial Officer	Aug 22 '25	Sale	13.79	22,315	307,657	309,273	Aug 26 04:14 PM
Hindson Benjamin J.	See Remarks	Aug 22 '25	Sale	13.79	7,486	103,209	440,888	Aug 26 04:12 PM
Saxonov Serge	Officer	Aug 22 '25	Proposed Sale	13.41	9,228	123,747		Aug 22 04:26 PM
Hindson Benjamin J.	Officer	Aug 22 '25	Proposed Sale	13.41	7,393	99,140		Aug 22 04:21 PM
Taich Adam	Officer	Aug 22 '25	Proposed Sale	13.41	22,037	295,516		Aug 22 04:17 PM
Saxonov Serge	Chief Executive Officer	May 22 '25	Sale	8.30	9,343	77,540	1,083,625	May 27 05:08 PM
Hindson Benjamin J.	See Remarks	May 22 '25	Sale	8.30	7,485	62,120	448,374	May 27 05:07 PM
Taich Adam	Chief Financial Officer	May 22 '25	Sale	8.30	4,044	33,562	331,588	May 27 05:06 PM
Hindson Benjamin J.	Officer	May 22 '25	Proposed Sale	9.08	7,392	67,119		May 22 04:44 PM
Taich Adam	Officer	May 22 '25	Proposed Sale	9.08	3,994	36,266		May 22 04:36 PM
Saxonov Serge	Officer	May 22 '25	Proposed Sale	9.08	9,227	83,781		May 22 04:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TXG

10x Genomics Inc

Upgrade your Finviz experience